Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03867799	TitleiSCORE: Immunotherapy Sequencing in COlon and REctal Cancer	Fase Fase 2	Date Added 2019-03-08	Ubicación Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Nivolumab	Etiquetas MSS/ MMRp
NCT ID NCT03865082	TitleStudy of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)	Fase Fase 2	Date Added 2019-03-06	Ubicación Arizona, United States California, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Ipilimumab, Nivolumab, Tilsotolimod, Opdivo, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT03860272	TitleFc-Engineered Anti-CTLA-4 Monoclonal Antibody Botensilimab in Advanced Cancer	Fase Fase 1	Date Added 2019-03-01	Ubicación Arizona, United States California, United States Colorado, United States Connecticut, United States Florida, United States Massachusetts, United States New York, United States Oregon, United States Texas, United States Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Balstilimab, Botensilimab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03851614	TitleBasket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors	Fase Fase 2	Date Added 2019-02-22	Ubicación Canadá	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Cediranib, durvalumab, Olaparib	Etiquetas MSS/ MMRp
NCT ID NCT03844750	TitlePembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery	Fase Fase 2	Date Added 2019-02-18	Ubicación California, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Pembrolizumab, Vactosertib, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT03835949	TitleStudy of TJ004309 in Combination With Atezolizumab (Tecentriq(R)) in Patients With Advanced or Metastatic Cancer	Fase Fase 1	Date Added 2019-02-11	Ubicación Alabama, United States Arizona, United States California, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Atezolizumab, TJ004309	Etiquetas MSS/ MMRp
NCT ID NCT03832855	TitleEvaluación de la inmunogenicidad de pING-hHER3FL	Fase Fase 1	Date Added 2019-02-06	Ubicación North Carolina, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas pING-hHER3FL	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03829462	TitleEvaluación de una combinación de regorafenib e irinotecán frente a regorafenib solo en pacientes con cáncer colorrectal metastásico	Fase Fase 3	Date Added 2019-02-04	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Irinotecan, Regorafenib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID LUMINESCENCE	TitleIpilimumab, Maraviroc and Nivolumab (LUMINESCENCE)	Fase Fase 1	Date Added 2019-01-25	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, maraviroc, Nivolumab, Celsentri, Opdivo, Selzentry, Yervoy	Etiquetas MSS/ MMRp
NCT ID NCT03796884	TitleLinaclotide in Treating Patients With Stages 0-3 Colorectal Cancer	Fase Fase 2	Date Added 2019-01-08	Ubicación Pennsylvania, United States Washington, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Linaclotide	Etiquetas MSS/ MMRp

Showing 201 to 210 of 299 entries